Document is current
Any future updates will be listed below
-
Authors
Nair, Rajiv Ranjit
Sarkar, Aira
Hariharan, Pooja
Gabrielson, Kathleen L.
Wu, Tony
Liu, Chang
Sharma, Anjali
Liyanage, Wathsala
Bhujwalla, Zaver M.
Vidaver, Marie-France Penet
Kannan, Rangaramanujam M.
Sofou, Stavroula https://orcid.org/0000-0003-1735-326X
-
Funding
Funding for this research was provided by:
Hartwell Foundation (N/A)
Uncle Kory Foundation (N/A)
- License Information
-
More Information
Article History
Received: 8 March 2025
Accepted: 29 April 2025
First Online: 14 May 2025
Declarations
:
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: SS, RRN and RMK are co-inventors in a pending patent involving this work. RMK is a co-founder and former board member of Ashvattha Therapeutics, Inc. Under license agreements involving Ashvattha Therapeutics, Inc and the Johns Hopkins University, RMK and Johns Hopkins University are entitled to royalty distributions related to products discussed in this manuscript. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. RMK is an inventor of patents licensed by Ashvattha, relating to the hydroxyl dendrimer-drug compositions.
